EMV vs SPL

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

EMV

EMVISION FPO [EMV]

51MEDIUM

SPL

STARPHARMA FPO [SPL]

58MEDIUM

Score Breakdown

EMV SPL
Technical
65
72
Catalyst
50
58
Sentiment
50
50
Fundamental
70
80
Momentum
39
80
Risk Gate
50
50

Key Metrics

EMV Metric SPL
$139.9MMarket Cap$315.7M
37KAvg Volume (20d)794K
N/AShort Interest+0.1%
$2.43052-Week High$0.790
$1.47052-Week Low$0.094
+3.0%Daily Change+5.1%
$1.550Reference Price$0.767
-58.0%ROE-14.5%
-188.0%Profit Margin-22.2%

Active Signals

EMV Signals

●MACD momentum is picking up steam
●Bollinger Bands are tightening — volatility is coiling up for a potential breakout
●Below the 200-day average — the long-term trend is still working against it
●Adequate cash runway (8 quarters)
●Moderate revenue growth (+11%)
●EPS estimates revised upward (+6pts)
●Near 52-week low (4% of range)
●Deeply negative margins (-188%)

SPL Signals

●MACD momentum is picking up steam
●Pressing against the upper Bollinger Band — extended and may need to cool off
●Trading above both moving averages — the trend is your friend here
●Watch out — volume is flowing out even as price holds up. Distribution pattern
●Knocking on the door of resistance — if it punches through, things could get interesting
●Beating the Small Ords index — relative strength of 1.18, so it's outpacing the pack
●Trading above the 200-day average — the long-term trend is on your side
●Strong cash runway (86 quarters)

Ask Scout AI to compare EMV and SPL in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

ENL vs HIQ →ENL vs LGP →ENL vs MSB →ENL vs MVF →ENL vs OCC →
EMV Full Analysis → SPL Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).